Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Natasha C. Klingenberg"'
Autor:
Heng Yu, Hunter F. Douglas, Donald Wathieu, Ryan A. Braun, Christine Edomwande, Daniel J. Lightell Jr., Thaidan Pham, Natasha C. Klingenberg, Shelia Pugh Bishop, Damir B. Khismatullin, T. Cooper Woods
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background Atherosclerosis is a common co-morbidity of type 2 diabetes mellitus. Monocyte recruitment by an activated endothelium and the pro-inflammatory activity of the resulting macrophages are critical components of atherosclerosis. Exos
Externí odkaz:
https://doaj.org/article/c0c99071de8843f9b17cdbb4ce6cd910
Autor:
Hernan A. Bazan, Ashton J. Brooks, Kenny Vongbunyong, Christin Tee, Hunter F. Douglas, Natasha C. Klingenberg, T. Cooper Woods
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Atherosclerotic plaque rupture is the etiology of ischemic stroke and myocardial infarction. The molecular mechanisms responsible for rupture remain unclear, in part, due to the lack of data from plaques at the time of rupture. Ribosome-depl
Externí odkaz:
https://doaj.org/article/9a12952fdb3e4c2098a91a2edb791018
Autor:
Akemi Katsurada, Ryousuke Satou, Vivian Fonseca, Kayoko Miyata, Courtney M Dugas, L. Gabriel Navar, T. Cooper Woods, Natasha C Klingenberg
Publikováno v:
American Journal of Nephrology. 49:331-342
Background: Hypertension and renal injury are common complications of type 2 diabetes mellitus (T2DM). Hyperglycemia stimulates renal proximal tubular angiotensinogen (AGT) expression via elevated oxidative stress contributing to the development of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22f47c275dd58fb74d64cd93167e4c02
https://doi.org/10.1159/000499597
https://doi.org/10.1159/000499597
Autor:
Akemi Katsurada, Kayoko Miyata, Natasha C Klingenberg, L. Gabriel Navar, Ryousuke Satou, Courtney M Dugas, T. Cooper Woods
Publikováno v:
Hypertension. 72
SGLT2 inhibitors lower blood glucose (BG) levels and have the potential to reduce cardiovascular and renal complications of type 2 diabetes mellitus (T2DM). Since BG levels can vary significantly during a treatment regime, hemoglobin A1c is often uti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6142d4ec08a3d411fc49a6872709bcb9
https://doi.org/10.1161/hyp.72.suppl_1.p327
https://doi.org/10.1161/hyp.72.suppl_1.p327